1887

Abstract

SUMMARY

Monoclonal antibodies to the lipopolysaccharide (LPS) core region were produced by immunising mice with strain J5 (chemotype Rc). One of these bound to the deepest part of the core, i.e., Lipid A, and reacted with other heat-killed but not live gram-negative bacilli, including and . Eight other monoclonal antibodies, binding to the terminal glucose residue of Rc LPS, reacted with live cells of strains only. Thus, the O antigen does not necessarily render the core inaccessible to antibody. However, despite binding to live bacteria, these monoclonal antibodies neither enhanced phagocytic killing, nor protected mice from dying from gram-negative infection or endotoxaemia. It is concluded that antibodies reacting with the most immunodominant parts of the J5 core are not protective.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-26-2-107
1988-06-01
2024-10-09
Loading full text...

Full text loading...

/deliver/fulltext/jmm/26/2/medmicro-26-2-107.html?itemId=/content/journal/jmm/10.1099/00222615-26-2-107&mimeType=html&fmt=ahah

References

  1. Appelmelk B. J., VughtA M. J. J., MacLaren D. M., Thijs L. G. 1985; An enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies to different parts of the Gram-negative lipopolysaccharide core region. Journal of Immunological Methods 82:199–207
    [Google Scholar]
  2. Bogard W. C., Abemethy K., Dunn D. L., Kung P. C. 1984; Murine monoclonal antibodies against gram-negative bacterial core-glycolipid: criteria for cross-genera reactivity. Federation Proceedings 43:1682 abstract 1553
    [Google Scholar]
  3. Bruins S. C., Stumacher R., Johns M. A., McCabe W. R. 1977; Immunization with R mutants of Salmonella minnesota III. Comparison of the protective effect of immunization with Lipid A and the Re mutant. Infection and Immunity 17:16–20
    [Google Scholar]
  4. DeHaan P., DeJonge A. J. R., Verbrugge T., Boorsma D. M. 1985; Three epitope-specific monoclonal antibodies against the hapten penicillin. International Archives of Allergy and Applied Immunology 76:42–46
    [Google Scholar]
  5. Dunn D. L., Mach P. A., Cerra F. B. 1983; Monoclonal antibodies protect against lethal effects of Gram-negative bacterial sepsis. Surgical Forum 44:142–143
    [Google Scholar]
  6. Dunn D. L., Bogard W. C., Cerra F. B. 1985; Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis. Surgery 98:283–290
    [Google Scholar]
  7. Dunn D. L., Ewald D. C., Chandan N., Cerra F. B. 1986; Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection. Archives of Surgery 121:58–62
    [Google Scholar]
  8. Elkins K., Metcalf E. S. 1985; Binding activity of a murine antiLipid A monoclonal antibody. Infection and Immunity 48:597–600
    [Google Scholar]
  9. Finney D. J. 1971; Statistical method in biological assay. 2nd edn Griffin; London: p 524
    [Google Scholar]
  10. Galanos C., Luderitz O., Westphal O. 1971; Preparation and properties of antisera against the Lipid A component of bacterial lipopolysaccharides. European Journal of Biochemistry 24:116–122
    [Google Scholar]
  11. Galanos C. 1984; Immunogenic properties of Lipid A. Reviews of Infectious Diseases 6:546–552
    [Google Scholar]
  12. Gigliotti F., Shenep J. L. 1985; Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli. Journal of Infectious Diseases 151:1005–1011
    [Google Scholar]
  13. Johns M., Skehill A., McCabe W. R. 1983; Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. Journal of Infectious Diseases 147:57–67
    [Google Scholar]
  14. Kasai N. 1985; In-vitro antigenic reactivity of synthetic Lipid A analogues as determined by monoclonal and conventional antibodies. Biochemical and Biophysical Research Communications 128:607–612
    [Google Scholar]
  15. Marks M. I., Ziegler E. J., Douglas H., Corbeil L. B., Braude A. I. 1982; Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. Journal of Clinical Investigation 69:742–749
    [Google Scholar]
  16. Miner K. M. 1986; Characterization of murine monoclonal antibodies to Echerichia coli J5. Infection and Immunity 52:56–62
    [Google Scholar]
  17. Mullan N. A., Newsome P. M., Cunnington P. G., Palmer G. H., Wilson M. E. 1974; Protection against gram-negative infections with antiserum to Lipid A from Salmonella minnesota R595. Infection and Immunity 10:1195–1201
    [Google Scholar]
  18. Mutharia L. M., Crockford G., Bogard W. C., Hancock R. E. W. 1984; Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species. Infection and Immunity 45:631–636
    [Google Scholar]
  19. Nelles M. J., Niswander C. A. 1984; Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria. Infection and Immunity 46:677–681
    [Google Scholar]
  20. Perlmutter R. M., Hansburg D., Briles D. E., Nicolotti R. A., Davie J. M. 1978; Subclass restriction of murine anti-carbohydrate antibodies. Journal of Immunology 121:566–572
    [Google Scholar]
  21. Peter G., Chemow M., Keating M. H., Ryff J. C., Zinner S. H. 1982; Limited protective effect of rough mutant antisera in murine Escherichia coli bacteremia. Infection 10:228–232
    [Google Scholar]
  22. Raubitschek A. A., Pollack M., Larrick J. W. 1985; Preparation of human monoclonal antibodies (mAbs) that react with the conserved core region of endotoxin (LPS). Clinical Research 33:416 A
    [Google Scholar]
  23. Rietschel E. T., Galanos C. 1977; Lipid antiserum-mediated protection against lipopolysaccharide- and Lipid A-induced fever and skin necrosis. Infection and Immunity 15:34–49
    [Google Scholar]
  24. Telzak E. E., Wolff S. M. 1985; Immunotherapy and immunoprophylaxis of Gram-negative rod bacteremia. In Root R. K., Sande M. A. (eds) Septic shock. Churchill Livingstone; New York: pp 257–276
    [Google Scholar]
  25. Teng N. N. H. 1985; Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proceedings of the National Academy of Sciences of the USA 82:1790–1794
    [Google Scholar]
  26. Vel Namavar F., VughtA M. J. J., Pubben A. N. B., MacLaren D. M. 1985; Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis. Journal of Clinical Pathology 38:86–91
    [Google Scholar]
  27. Verweij-van VughtA M. J. J., den Bosch J. F., Namavar F., Sparrius M., MacLaren D. M. 1983; K antigens of Escherichia coli and virulence in urinary tract infection: studies in a mouse model. Journal of Medical Microbiology 16:147–155
    [Google Scholar]
  28. Young L. S. 1984; Monoclonal antibodies: technology and application to gram-negative infections. Infection 12:303–308
    [Google Scholar]
  29. Ziegler E. J. 1982; Treatment of gram-negative bacteremia and shock with human antiserum to a mutant of Escherichia coli. New England Journal of Medicine 307:1225–1230
    [Google Scholar]
  30. Zierdt C. H. 1982; Blood-lysing solution nontoxic to pathogenic bacteria. Journal of Clinical Microbiology 15:172–174
    [Google Scholar]
  31. Zinner S. H., Peter G. 1983; The potential role of cell wall core glycolipids in the immunoprophylaxis and immunotherapy of gram-negative rod bacteriaemia. In Easmon C. S. F., Jeljaszewicz J. (eds) Medical microbiology vol 2 Immunization against bacterial disease. Academic Press; London: pp 71–85
    [Google Scholar]
/content/journal/jmm/10.1099/00222615-26-2-107
Loading
/content/journal/jmm/10.1099/00222615-26-2-107
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error